Gadolinium Contrast
Gadolinium Contrast - Related Videos
05:15
An Aptamer-based Sensor for Unchelated Gadolinium(III)
0 Views •
2017
The use of polydeoxynucleotide (44-mer aptamer) molecules for sensing unchelated gadolinium(III) ion in an aqueous solution is described. The presence of the ion is detected via an increase in the fluorescence emission of the sensor.
06:49
Phase Contrast and Differential Interference Contrast (DIC) Microscopy
0 Views •
Cited by 25 •
2008
This protocol highlights the principles and practical applications of Phase and Differential Interference Contrast (DIC)...
11:27
Preparation and In Vitro Characterization of Dendrimer-based Contrast Agents for Magnetic Resonance Imaging
0 Views •
Cited by 5 •
2016
This protocol describes the preparation and characterization of a dendrimeric magnetic resonance imaging (MRI) contrast agent that carries cyclen-based macrocyclic chelates coordinating paramagnetic gadolinium ions. In a series of MRI experiments in vitro, this agent produced an amplified MRI signal when compared to the commercially available monomeric analogue.
06:54
MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
0 Views •
Cited by 3 •
2013
To demonstrate MR cancer molecular imaging with a small peptide targeted MRI contrast agent specific to clotted plasma proteins in tumor stroma in a mouse prostate cancer model.
01:26
Phase Contrast and Differential Interference Contrast Microscopy
0 Views •
2023
Phase-Contrast Microscopes In-phase-contrast microscopes, interference between light directly passing through a cell and light refracted by cellular components is used to create high-contrast, high-resolution images without staining. It is the oldest and simplest type of microscope that creates an image by altering the wavelengths of light rays passing through the specimen. Altered wavelength paths are created using an annular stop in the condenser. The annular stop produces a hollow cone of...
FAQs
Enclosure within a chelating molecule helps limit gadolinium’s biological reactivity while allowing the agent to influence nearby water protons. This pairing is central to its imaging role: the gadolinium ion supplies paramagnetic behavior, whereas the chelator supports safer handling of the ion in the biological environment.
By changing nearby water-proton relaxation, the agent alters signal intensity on T1-weighted images. Regions that interact differently with the agent can therefore become more distinguishable from surrounding tissue. This mechanism is especially useful when the imaging goal is to separate normal anatomy from vascular or pathological regions rather than simply display structure without enhancement.
Dose, renal function, and the specific agent are important safety considerations because GBCAs can be associated with retention and adverse reactions. These variables should be considered before administration and when interpreting the risk of an imaging study. Attention to them helps researchers and clinicians balance the desired enhancement against biological and agent-specific safety concerns.
An imaging workflow administers the agent by injection and then acquires MRI data, including T1-weighted images suited to the resulting signal change. The enhanced study can be examined for differences among tissues, blood vessels, and suspected pathological regions. Dose selection, renal-function assessment, and awareness of agent-specific safety are important parts of planning.
In biomedical research, enhanced MRI can be used to examine tissue perfusion, inflammation, tumors, and blood-brain barrier disruption. These applications extend beyond depicting anatomy alone: they use differences in enhancement to investigate physiological or pathological features. The same approach can support studies of vascular behavior and disease-associated changes when those regions become more visible after administration.
Gadolinium-enhanced MRI can make blood-brain barrier disruption more visible, giving biology and biomedical research a way to investigate an important boundary-related change in tissue. In this context, enhancement is not merely a brighter image; it can help identify regions where pathological processes alter the expected separation between the blood and brain environments.